degradable starch microspheres

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Treatment efficacy in cancer patients using systemically applied cytostatic drugs is decreased by cytotoxic side effects, which… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2007
2007
BACKGROUND In a multidisciplinary conference patients with advanced non-resectable hepatocellular carcinoma (HCC) were stratified… (More)
Is this relevant?
2006
2006
AIM To observe the dynamic changes of liver microcirculation in vivo after arterial embolization with degradable starch… (More)
Is this relevant?
2005
2005
Degradable starch microspheres (DSMs) provide transient occlusion of small arteries and are thought to improve the therapeutic… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2003
2003
We prospectively evaluated the efficacy and safety of transcatheter arterial chemoembolization (TACE) with microembolization… (More)
Is this relevant?
Review
1994
Review
1994
The use of particulate embolic agents combined with regional chemotherapy in the treatment of hepatocellular carcinoma and… (More)
Is this relevant?
1994
1994
The effect of the nasal administration of degradable starch microspheres (DSM) on the mucociliary system and the geometry of the… (More)
Is this relevant?
1989
1989
The role of vascularity as a prognostic factor was investigated in 35 patients undergoing arterial chemotherapy for liver tumours… (More)
Is this relevant?
1986
1986
Twenty four patients with incurable primary or metastatic liver cancer were treated with hepatic arterial Mitomycin C admixed… (More)
Is this relevant?
1985
1985
Intraarterial administration of 40-microns degradable starch microspheres (DSM) in a drug solution can temporarily retard flow of… (More)
  • table 1
  • table 2
Is this relevant?